CIBC World Market
SEEL

CIBC World Market’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

CIBC World Market’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-130
Closed -$468K – 1344
2020
Q3 		$468K Buy
130
+52
+67% +$187K ﹤0.01% 840
2020
Q2 		$303K Buy
+78
New +$259K ﹤0.01% 915

Other funds holding SEEL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
1CM
1492 Capital Management Milwaukee, Wisconsin $263M AUM 61.9% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIBC World Market's SEEL Position: Q4 2020 in Review

CIBC World Market sold out of Seelos Therapeutics, Inc. Common Stock (SEEL) in Q4 2020, closing a stake of 130 shares — an estimated $468K sold.

CIBC World Market first reported a position in SEEL in Q2 2020 and held it in 2 quarters. The position peaked at $468K in Q3 2020. 26 funds tracked by Wall St. Rank hold SEEL as of Q4 2020.

  • CIBC World Market reported no remaining Seelos Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • CIBC World Market sold 130 Seelos Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $468K.
  • CIBC World Market first reported a position in Seelos Therapeutics, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • CIBC World Market's Seelos Therapeutics, Inc. Common Stock position peaked at $468K in Q3 2020.
  • 26 funds tracked by Wall St. Rank held Seelos Therapeutics, Inc. Common Stock as of Q4 2020.

Based on CIBC World Market's 13F filing for Q4 2020, filed 8 Feb 2021.